Who to call at CervoMed Inc., and when
Fundz watches for the moments CervoMed Inc. starts buying, and tells you who to reach.
- An alert the day CervoMed Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CervoMed Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CervoMed Inc.. With Fundz connected, it knows.
CervoMed Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
diffusionpharma.comAI Executive Summary
AI-powered analysis of 8-K filing content
CervoMed appointed David Quigley, a former McKinsey & Company Senior Partner with over 25 years at the firm, as a director on October 27, 2025, and expanded the Board from seven to eight members. The filing discloses a 16,200-share option grant at $7.02 per share, the closing price on the grant date.
Key Takeaways
David Quigley, a former McKinsey & Company Senior Partner (2010 to 2025) with life sciences and private capital leadership experience, joined the Board on October 27, 2025.
The Board was expanded from seven to eight members to accommodate the appointment.
3 more takeaways
Related Filings (26)
26 more filings from CervoMed Inc. in the last 90 days
Filing Overview
What This Means
CervoMed Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.